The Medicines and Health products Regulatory Agency (MHRA) has issued a class three medicines recall for AlfaD Capsules of Theramex.

Theramex Ireland Ltd T/A Theramex HQ UK Ltd has informed the MHRA of an issue related to error in the decommissioning of the capsule batches.

“Upon decommissioning at the pharmacy and when scanning the serialised 2D code, the status of packs may report as ‘EXPORT’. Although there is no risk to product quality, any remaining stock should be quarantined and returned,” MHRA has said in the drug alert released on Thursday (October 29).

Product details

AlfaD 0.25 microgram capsules PL 49876/0001

Batch Number Expiry Date Pack Size First Distributed
A04285 Apr 2022 30 15 Sep 2020

 

AlfaD 1 microgram capsules PL 49876/0003

Batch Number Expiry Date Pack Size First Distributed
106389 Aug 2022 30 15 Sep 2020

 

AlfaD 0.25 microgram capsules PL 49876/0001

Batch Number Expiry Date Pack Size First Distributed
A04279A 31 Jan 2022 30 26 Mar 2020

 

Community pharmacists have been advised to stop supplying the batches immediately and quarantine all remaining stock and return it to the concerned supplier using their supplier’s approved process.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY